MedTech News
Tandem picks up FDA clearance for 7-day infusion set
Tandem Diabetes Care (Nasdaq:TNDM) has a new infusion set on the way to pair with its insulin delivery offerings.
Nerveblox, the Ultrasound AI for Regional Anesthesia, Receives FDA Clearance
ANKARA, Türkiye, Aug. 18, 2025 /PRNewswire/ — Nerveblox, an AI software solution by SmartAlpha, designed to assist physicians in using ultrasound while administering regional anesthesia procedures commonly known as ‘nerve blocks’, has received U.S. Food and Drug Administration (FDA) 510(k) clearance.
MIGHT: Powerful new algorithm advances reliability of AI with applications in medical diagnostics
Two studies led by Johns Hopkins Kimmel Cancer Center, Ludwig Center, and Johns Hopkins Whiting School of Engineering researchers report on a powerful new method that significantly improves the reliability and accuracy of artificial intelligence (AI) for many applications.
An alternative to LASIK—without the lasers
Millions of Americans have altered vision, ranging from blurriness to blindness. But not everyone wants to wear prescription glasses or contact lenses. Accordingly, hundreds of thousands of people undergo corrective eye surgery each year, including LASIK—a laser-assisted surgery that reshapes the cornea and corrects vision.
Labcorp Launches First FDA-Cleared Blood Test for Alzheimer’s Disease
BURLINGTON, N.C., Aug. 18, 2025 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the availability of the Lumipulse® pTau-217/Beta Amyloid 42 Ratio, the first blood-based in-vitro diagnostic (IVD) test cleared by the U.S. Food and Drug Administration (FDA) to aid in the diagnosis of Alzheimer’s disease.
Biomerica receives approval in UAE for at-home ulcer test
The company is collaborating with local companies and healthcare providers to distribute the ulcer test.
NeuroOne wins FDA nod for nerve ablation system that treats facial pain
NeuroOne (Nasdaq:NMTC) announced today that it received FDA clearance for its OneRF trigeminal nerve ablation system.
Onward wins FDA IDE for spinal cord stimulation to address blood pressure instability
Onward Medical announced today that it received FDA investigational device exemption (IDE) for its ARC-IM system.